Cardiovascular Diabetology is affiliated with Sackler Faculty of Medicine, Tel-Aviv University
Class effects of SGLT2 inhibitors on cardiorenal outcomes
To summarize the four recent sodium-glucose cotransporter 2 inhibitor (SGLT2i) trials: Dapagliflozin Effect on CardiovascuLAR Events (DECLARE-TIMI 58), CANagliflozin CardioVascular Assessment Study (CANVAS) Pr...